|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/4162 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2358717 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09756204.5 |
| Date of filing the European patent application | 2009-11-11 | |
| (97) | Date of publication of the European application | 2011-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2013-08-21 |
| (46) | Date of publication of the claims translation | 2013-12-27 |
| (86) | Number | PCT/US2009/063976 |
| Date | 2009-11-11 |
| (87) | Number | WO 2010/056708 |
| Date | 2010-05-20 |
| (30) | Number | Date | Country code |
| 199179 P | 2008-11-13 | US |
| (72) |
BIFTU, Tesfaye, US
CHEN, Ping, US
COX, Jason, M., US
WEBER, Ann, E., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Aminotetrahidropiranai, kaip dipeptidilpeptidazės-IV inhibitoriai, skirti diabeto gydymui arba prevencijai |
| AMINOTETRAHYDROPYRANS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES |
| Payment date | Validity (years) | Amount | |
| 2017-11-07 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-11-11 |